|
1）Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001; 95: 190-8
|
|
|
|
2）Stummer W, Stocker S, Wagner S, et al. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery. 1998; 42: 518-25; discussion 25-6
|
|
|
|
|
|
3）Stummer W, Pichlmeier U, Meinel T, et al. Fluorescence-guided surgery with 5-amino-levulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol. 2006; 7: 392-401
|
|
|
|
|
|
4）井上克司，中島元夫，田中 徹．5-アミノレブリン酸を用いた腫瘍の光動力学診断のための医療研究機器．Medical Science Digest. 2012; 38: 30-4
|
|
|
|
|
|
5）Ferreira LM. Cancer metabolism: the Warburg effect today. Exp Mol Pathol. 2010; 89: 372-80
|
|
|
|
|
|
6）Nabavi A, Thurm H, Zountsas B, et al. Five-aminolevulinic acid for fluorescence-guided resection of recurrent malignant gliomas: a phase ii study. Neurosurgery. 2009; 65: 1070-6; discussion 6-7
|
|
|
|
|
|
7）Roberts DW, Valdes PA, Harris BT, et al. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between delta-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuro-pathological parameters. Clinical article. J Neuro-surg. 2011; 114: 595-603
|
|
|
|
|
|
8）Utsuki S, Oka H, Sato S, et al. Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. Neurol Med Chir (Tokyo). 2007; 47: 210-3; discussion 3-4
|
|
|
|
|
9）Ewelt C, Floeth FW, Felsberg J, et al. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intra-operative, ALA-derived tissue fluorescence. Clin Neurol Neurosurg. 2011; 113: 541-7
|
|
|
|
|
|
10）Floeth FW, Sabel M, Ewelt C, et al. Comparison of (18)F-FET PET and 5-ALA fluorescence in cerebral gliomas. Eur J Nucl Med Mol Imaging. 2011; 38: 731-41
|
|
|
|
|
|
11）Arita H, Kinoshita M, Kagawa N, et al. 11C-methionine uptake and intraoperative 5-aminolevulinic acid-induced fluorescence as separate index markers of cell density in glioma: a stereotactic image-histological analysis. Cancer. 2011; 118: 1619-27
|
|
|
|
|
|
12）Idoate MA, Diez Valle R, Echeveste J, et al. Pathological characterization of the glioblastoma border as shown during surgery using 5-amino-levulinic acid-induced fluorescence. Neuropatho-logy. 2011; 31: 575-82
|
|
|
|
|
|
13）Valdes PA, Kim A, Brantsch M, et al. delta-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resec-tion to identify regions of increasing malignancy. Neuro Oncol. 2011; 13: 846-56
|
|
|
|
|
|
14）Widhalm G, Wolfsberger S, Minchev G, et al. 5-Aminolevulinic acid is a promising marker for detection of anaplastic foci in diffusely infiltrating gliomas with nonsignificant contrast enhance-ment. Cancer. 2010; 116: 1545-52
|
|
|
|
|
|
15）Johansson A, Palte G, Schnell O, et al. 5-Aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors. Photochem Photobiol. 2010; 86: 1373-8
|
|
|
|
|
|
16）Valdes PA, Leblond F, Kim A, et al. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker. J Neurosurg. 2011; 115: 11-7
|
|
|
|
|
|
17）Valdes PA, Moses ZB, Kim A, et al. Gadolinium- and 5-aminolevulinic acid-induced protopor-phyrin IX levels in human gliomas: An Ex Vivo Quantitative Study to Correlate Protoporphyrin IX Levels and blood-brain barrier breakdown. J Neuropathol Exp Neurol. 2012; 71: 806-13
|
|
|
|
|
|
18）Stockhammer F, Misch M, Horn P, et al. Association of F18-fluoro-ethyl-tyrosin uptake and 5-aminolevulinic acid-induced fluorescence in gliomas. Acta Neurochir (Wien). 2009; 151: 1377-83
|
|
|
|
|
|
19）Panciani PP, Fontanella M, Schatlo B, et al. Fluorescence and image guided resection in high grade glioma. Clin Neurol Neurosurg. 2011; 114: 37-41
|
|
|
|
|
|
20）Miyatake S, Kuroiwa T, Kajimoto Y, et al. Fluorescence of non-neoplastic, magnetic reso-nance imaging-enhancing tissue by 5-aminolevulinic acid: case report. Neurosurgery. 2007; 61: E1101-3; discussion E3-4
|
|
|
|
|
|
21）Moriuchi S, Yamada K, Dehara M, et al. Use of 5-aminolevulinic acid for the confirmation of deep-seated brain tumors during stereotactic biopsy. Report of 2 cases. J Neurosurg. 2011; 115: 278-80
|
|
|
|
|
|
22）Bekelis K, Valdes PA, Erkmen K, et al. Quantitative and qualitative 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in skull base meningiomas. Neurosurg Focus. 2011; 30: E8
|
|
|
|
|
|
23）Tamura Y, Kuroiwa T, Kajimoto Y, et al. Endoscopic identification and biopsy sampling of an intraventricular malignant glioma using a 5-aminolevulinic acid-induced protoporphyrin IX fluorescence imaging system. Technical note. J Neurosurg. 2007; 106: 507-10
|
|
|
|
|
|
24）Pichlmeier U, Bink A, Schackert G, et al. Resection and survival in glioblastoma multi-forme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol. 2008; 10: 1025-34
|
|
|
|
|
|
25）Stummer W, Reulen HJ, Meinel T, et al. Extent of resection and survival in glioblastoma multi-forme: identification of and adjustment for bias. Neurosurgery. 2008; 62: 564-76; discussion -76
|
|
|
|
|
|
26）Webber J, Kessel D, Fromm D. Side effects and photosensitization of human tissues after amino-levulinic acid. J Surg Res. 1997; 68: 31-7
|
|
|
|
|
|
27）Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352: 987-96
|
|
|
|
|
|
28）Chang SM, Parney IF, Huang W, et al. Patterns of care for adults with newly diagnosed malignant glioma. JAMA. 2005; 293: 557-64
|
|
|
|
|
|
29）Senft C, Bink A, Franz K, et al. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol. 2011; 12: 997-1003
|
|
|
|
|
|
30）Schucht P, Beck J, Abu-Isa J, et al. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-ALA intraoperative fluorescence imaging and brain mapping. Neurosurgery. 2012. Epub 2012/08/17
|
|
|
|
|
|
31）Tsugu A, Ishizaka H, Mizokami Y, et al. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. World Neurosurg. 2011; 76: 120-7
|
|
|
|
|
|
32）Sanai N, Snyder LA, Honea NJ, et al. Intra-operative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas. J Neurosurg. 2011; 115: 740-8
|
|
|
|
|